Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic ...

KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and ...
India Today on MSN

Class 7 students to study more about Ghazni raids and killings in new NCERT textbook

The newly released Class 7 NCERT social science textbook gives students a more detailed look at the Ghaznavid invasions, ...
Princeton University

Treasured ‘third spaces’ on campus help students contemplate, connect and find community

As reading period and final exams begin, we visit some favorite spots for students to study, catch up with friends, or simply ...
EurekAlert!

Antibiotics could trigger immune response through gut microbiome metabolites

The microbes inside our bodies not only help break down food but also impact our health. Yet their precise influence is not always understood, especially in the presence of prescription drugs. Now, ...

First U.S. Hemp-Biosolids Trial Tests Breakthrough Sustainable Fertilizer

A first-of-its-kind U.S. field trial is underway to explore how Class A biosolids can be used as a sustainable fertilizer for industrial hemp grain and fiber production. Led by Dr. D.K. Lee and a team ...